Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse®
- Details
- Category: Shire
![Shire Shire](/images/stories/logo/shire.gif)
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Genzyme Statement on Discussions With Sanofi-Aventis
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
US Food and Drug Administration extend review timeline for vandetanib
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
KOMBIGLYZE™ XR Now Available in U.S. Pharmacies
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
FDA grants supplemental approval for ACTEMRA
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
More Pharma News ...
- Daxas® (Roflumilast) included as a new treatment option in latest international COPD guidelines
- Merck KGaA Acquires Supplier to Biopharma Industry in China
- GSK responds to 60 Minutes | Related Video
- First two clinical phase III studies confirm the profile of nalmefene
- European Commission approves Tasigna® for treatment of patients with newly diagnosed Ph+ chronic myeloid leukemia
- Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery Technology
- Pfizer Submits Applications to Expand the Use of Prevnar 13® to Adults 50 and Older